Business Description
New Nordic Healthbrands AB
ISIN : SE0001838038
Total Employee Number:
78Compare
Compare
Traded in other countries / regions
NNH.SwedenN9X.Germany IPO Date
2024-08-29Description
New Nordic Healthbrands AB develops herbal supplements, herbal remedies, and personal care products to satisfy specific health and beauty needs. The products are sold in North America, Europe, and Asia. Some products sold are Active legs, Active Liver, Apple Cider, Chili Burn, Clear brain, Ear tone, Equazen, Frutin gastro gel, Hair Gro, Hair Volume, Kilo trim, and Melissa Dream. Maximum revenue is generated from the Nordic region.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.22 | |||||
Equity-to-Asset | 0.39 | |||||
Debt-to-Equity | 0.39 | |||||
Debt-to-EBITDA | 3.51 | |||||
Interest Coverage | 4.43 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 2.9 | |||||
Beneish M-Score | -2.45 | |||||
WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 5.7 | |||||
3-Year Book Growth Rate | -2.8 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 32.35 | |||||
9-Day RSI | 34.6 | |||||
14-Day RSI | 33.67 | |||||
3-1 Month Momentum % | -29.76 | |||||
6-1 Month Momentum % | -34.26 | |||||
12-1 Month Momentum % | -31.59 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.51 | |||||
Quick Ratio | 0.79 | |||||
Cash Ratio | 0.05 | |||||
Days Inventory | 196.66 | |||||
Days Sales Outstanding | 62.08 | |||||
Days Payable | 154.68 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 2.19 | |||||
Forward Dividend Yield % | 2.19 | |||||
5-Year Yield-on-Cost % | 2.14 | |||||
Shareholder Yield % | 7 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 63.74 | |||||
Operating Margin % | 1.55 | |||||
Net Margin % | 0.47 | |||||
EBITDA Margin % | 2 | |||||
FCF Margin % | -0.12 | |||||
OCF Margin % | 0.64 | |||||
ROE % | 2.63 | |||||
ROA % | 1.06 | |||||
ROIC % | 1.67 | |||||
3-Year ROIIC % | -46.95 | |||||
ROC (Joel Greenblatt) % | 8.45 | |||||
ROCE % | 8.4 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 28.84 | |||||
PE Ratio without NRI | 28.84 | |||||
Shiller PE Ratio | 5.44 | |||||
PS Ratio | 0.14 | |||||
PB Ratio | 0.75 | |||||
Price-to-Tangible-Book | 0.79 | |||||
Price-to-Operating-Cash-Flow | 20.33 | |||||
EV-to-EBIT | 12.25 | |||||
EV-to-EBITDA | 9.51 | |||||
EV-to-Revenue | 0.19 | |||||
EV-to-FCF | -201.15 | |||||
Price-to-GF-Value | 0.61 | |||||
Price-to-Projected-FCF | 0.97 | |||||
Price-to-Median-PS-Value | 0.25 | |||||
Price-to-Graham-Number | 0.99 | |||||
| Price-to-Net-Current-Asset-Value | 0.95 | |||||
Earnings Yield (Greenblatt) % | 8.16 | |||||
FCF Yield % | -0.71 | |||||
Forward Rate of Return (Yacktman) % | -8.6 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
New Nordic Healthbrands AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 51.754 | ||
| EPS (TTM) (€) | 0.038 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 67.87 | ||
| 14-Day RSI | 33.67 | ||
| 14-Day ATR (€) | 0.017533 | ||
| 20-Day SMA (€) | 1.0755 | ||
| 12-1 Month Momentum % | -31.59 | ||
| 52-Week Range (€) | 1.035 - 2.4 | ||
| Shares Outstanding (Mil) | 6.2 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
New Nordic Healthbrands AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
New Nordic Healthbrands AB Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-10-30 | In 106 days | ||
| Second quarter earnings results for 2026 | 2026-07-31 | In 15 days | ||
| SEK 0.250000 Cash Dividend | 2026-04-30 | 1.76 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-04-29 | 1.76 (-0.28%) | ||
| General meeting for 2025 | 2026-04-29 | 1.76 (-0.28%) | ||
| Annual report for 2025 | 2026-04-08 | 1.55 (-0.96%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-28 | 1.81 (+5.25%) | ||
| Third quarter earnings results for 2025 | 2025-10-31 | 2.25 (+0.45%) | ||
| Second quarter earnings results for 2025 | 2025-07-31 | 2.08 (+0.97%) | ||
| General meeting for 2024 | 2025-04-30 10:00 | 1.61 (+25.88%) |
Show
Entries
New Nordic Healthbrands AB Frequently Asked Questions
What is New Nordic Healthbrands AB(FRA:N9X)'s stock price today?
The current price of FRA:N9X is €1.05. The 52 week high of FRA:N9X is €2.40 and 52 week low is €1.03.
When is next earnings date of New Nordic Healthbrands AB(FRA:N9X)?
The next earnings date of New Nordic Healthbrands AB(FRA:N9X) is 2026-07-31 Est..
Does New Nordic Healthbrands AB(FRA:N9X) pay dividends? If so, how much?
The Dividend Yield %  of New Nordic Healthbrands AB(FRA:N9X) is 2.19% (As of Today), Highest Dividend Payout Ratio of New Nordic Healthbrands AB(FRA:N9X) was 0.61. The lowest was 0.12. And the median was 0.44. The  Forward Dividend Yield % of New Nordic Healthbrands AB(FRA:N9X) is 2.19%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on New Nordic Healthbrands AB
No articles.